Myeloma Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults between 18 and 75 years old who have been diagnosed with Multiple Myeloma that has come back or stopped responding to treatment, confirmed using standard diagnostic guidelines
• People who have already received at least one previous treatment course for their condition
• People whose general physical functioning falls within an acceptable range on a standard medical scale (scored 0 to 3 out of 5, where lower numbers indicate better functioning)
• People who are able to understand information about their treatment and follow the required check-up schedule throughout the study
• People who have signed a written consent form agreeing to take part

Who may not be able to join:

• People with serious problems affecting the heart, lungs, liver, or kidneys, based on specific test results falling outside set limits (confirm with trial site for exact thresholds)
• People who still have significant side effects from previous chemotherapy that have not returned to mild levels or to how they were before treatment
• People experiencing moderate or severe nerve damage (such as numbness, tingling, or pain in the hands or feet) from previous treatment
• People who have had major surgery, radiation therapy, a serious infection requiring antibiotics, or another severe infection within the 14 days before joining the trial
• People with a high-risk form of the disease where cancer plasma cells make up 20% or more of blood cells
• People with psychiatric conditions, cognitive difficulties, or other conditions that may affect their ability to follow the study requirements
• Women who are pregnant or breastfeeding, or people who are able to have children but are unwilling to use reliable contraception during the study
• Male participants who are unwilling to use effective contraception or avoid sperm donation during treatment and for 3 months after the final dose
• People who have been diagnosed with or treated for another cancer within the 2 years before joining
• People with a known allergy or sensitivity to any of the medications used in this trial, including Epunamin, Dexamethasone, Cisplatin, Etoposide, or Cyclophosphamide
• People who are HIV positive
• People who have taken part in another clinical trial within 30 days before joining, or who are currently in another trial
• People whom the trial doctor considers unsuitable for any other reason

Important: Always verify eligibility with the trial site directly before applying.